FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
March 27, 2006
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: March 27, 2006
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Smith & Nephew plc ('the Company')
Annual Information Update
The Company announces that in accordance with the requirements of Prospectus
Rule 5.2, the following information has been published or made available to the
public during the 12 months ended 10 March 2006 in compliance with laws and
rules dealing with the regulation of securities, issuers of securities and
securities markets.
For the purposes of this update the information is only referred to and full
copies of each item can be found at the locations specified below.
1. ANNOUNCEMENTS MADE VIA A REGULATORY INFORMATION SERVICE.
All documents listed below were published via RNS, a Regulatory News Service
provided by the London Stock Exchange, on the dates indicated.
Date Nature and Brief Description of Information
15.03.2005 Notification of Director's Shareholding - Sir Christopher O'Donnell.
16.03.2005 Announcement re Annual Report & Accounts Filed with the UKLA.
16.03.2005 Notification of Director's Shareholding - Sir Christopher O'Donnell.
16.03.2005 Notification of Director's Shareholding - Peter Hooley.
30.03.2005 Notification of Director's Shareholding - Sir Christopher O'Donnell.
30.03.2005 Notification of Director's Shareholding - Peter Hooley.
31.03.2005 Notification of DOJ Subpoena.
04.04.2005 Notification of Director's Shareholding - Peter Hooley.
04.04.2005 Notification of Director's Shareholding - John Buchanan.
08.04.2005 Timing of 2005 First Quarter Results.
05.05.2005 Announcement of 2005 First Quarter Results.
05.05.2005 Block Listing Six Monthly Return as at 30 April 2005.
06.05.2005 Document Available for Viewing at the UKLA re Resolutions
Passed at AGM.
09.05.2005 Notification of Director's Shareholding - Peter Hooley.
11.05.2005 Announcement re Smith & Nephew Endoscopy - Injunction on
Bi-Polar Sales Lifted.
13.05.2005 Notification of Director's Shareholding - Sir Christopher O'Donnell.
13.05.2005 Notification of Director's Shareholding -Dudley Eustace.
18.07.2005 Timing of 2005 Second Quarter & Interim Results.
02.08.2005 Notification of Major Interests in Shares - Barclays plc
holding 3.40%
04.08.2005 Announcement of Second Quarter & Interim Results.
08.08.2005 Notification of Director/PDMR Shareholding - Paul Williams.
08.08.2005 Notification of Director/PDMR Shareholding - James Dick.
08.08.2005 Notification of Director/PDMR Shareholding - Peter Huntley.
08.08.2005 Notification of Director/PDMR Shareholding -
Sir Christopher O'Donnell.
08.08.2005 Notification of Director/PDMR Shareholding - Peter Hooley.
17.08.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 3.02%.
18.08.2005 Smith & Nephew Prepares for Divestment of BSN Medical
Joint Venture.
19.08.2005 Notification of FDA Panel Hearing for Hip Resurfacing Product.
07.09.2005 Investor Visit to Smith & Nephew Orthopaedics.
13.09.2005 Notification of Trading Update.
14.09.2005 Notification of Change to Investor Visit Webcast Timing.
15.09.2005 Notification of Director/PDMR Shareholding - Paul Williams.
19.09.2005 Notification of Director/PDMR Shareholding - Dudley Eustace.
21.09.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 4.019%.
22.09.2005 Notification of Director/PDMR Shareholding - James Dick.
13.10.2005 Timing of 2005 Third Quarter Results.
14.10.2005 Notification of Director/PDMR Shareholding - David Illingworth.
14.10.2005 Notification of Director/PDMR Shareholding - James Ralston.
17.10.2005 Notification of Major Interests in Shares - The Capital Group
Companies, Inc holding 5.02%.
21.10.2005 Notification of Director/PDMR Shareholding - James Taylor.
24.10.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 6.09%.
27.10.2005 Announcement of 2005 Third Quarter Results.
28.10.2005 Notification of Director/PDMR Shareholding - Purchase of
Shares by Mourant & Co. Trustees Limited as Trustee of the Smith &
Nephew Employees' Share Trust.
01.11.2005 Notification of Director/PDMR Shareholding - Peter Hooley.
03.11.2005 Block Listing Six Monthly Return as at 31 October 2005.
04.11.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 7.17%.
15.11.2005 Notification of Director/PDMR Shareholding - Sir Christopher
O'Donnell.
15.11.2005 Notification of Director/PDMR Shareholding - Dudley Eustace.
16.11.2005 Notification of Director/PDMR Shareholding - Paul Williams.
16.11.2005 Notification of Director/PDMR Shareholding - James Dick.
17.11.2005 Notification of Director/PDMR Shareholding - James Dick.
17.11.2005 Circular Sent to Shareholders re Proposed Redenomination of Share
Capital into US Dollars.
28.11.2005 Announcement re Filing of Form 20-F/A with the SEC.
29.11.2005 Notification of Major Interests in Shares - Deutsche Bank
AG holding 3.33%.
08.12.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 8.11%.
12.12.2005 Document Available for Viewing at the UKLA re Resolutions
Passed at EGM.
16.12.2005 Announcement re Disposal of BSN Medical Joint Venture.
16.12.2005 Announcement re Realising Investment in BSN Medical.
23.12.2005 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 9.27%.
20.01.2006 Notification of Announcement Dates for 2006 and details of
the Briefing at the American Academy of Orthopaedic Surgeons.
23.01.2006 Share Capital Redenomination into US Dollars by Reduction
of Capital and Subsequent Issue & Allotment of New Dollar
Ordinary Shares.
23.01.2006 Notification of Director/PDMR Shareholding - David Illingworth.
23.01.2006 Notification of Director/PDMR Shareholding - James Ralston.
23.01.2006 Notification of Director/PDMR Shareholding - James Taylor.
02.02.2006 Notification of Board Change - Retirement of Peter Hooley
as Finance Director & Appointment of Adrian Hennah as Finance
Director in June 2006.
09.02.2006 Announcement of Results for the Fourth Quarter and Year
Ended 31 December 2005.
09.02.2006 Notification of Board Change - Retirement of Dudley Eustace
as Chairman at AGM on 27 April 2006. John Buchanan will take over as
Chairman with effect from the end of the Meeting.
09.02.2006 Management Appointments - Scott Flora appointed President
of Orthopaedic Reconstruction. Mark Augusti appointed President of
Orthopaedic Trauma & Clinical Therapies. Joe Woody appointed
President of Advanced Wound Management.
13.02.2006 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 10.54%.
14.02.2006 Notification of Director/PDMR Shareholding - John Buchanan.
15.02.2006 Notification of Major Interests in Shares - The Capital Group
Companies, Inc holding 11.19%.
15.02.2006 Notification of Director/PDMR Shareholding - Dudley Eustace.
23.02.2006 Notification of Major Interests in Shares - The Capital
Group Companies, Inc holding 12.25%.
24.02.2006 Disposal of 50% Stake in BSN Medical Completed.
28.02.2006 Notification of Director/PDMR Shareholding - David Illingworth.
08.03.2006 Notification of Director/PDMR Shareholding - Sir Christopher
O'Donnell.
08.03.2006 Notification of Director/PDMR Shareholding - Peter Hooley.
08.03.2006 Notification of Director/PDMR Shareholding - James Dick.
08.03.2006 Notification of Director/PDMR Shareholding - David Illingworth.
08.03.2006 Notification of Director/PDMR Shareholding - Peter Huntley.
08.03.2006 Notification of Director/PDMR Shareholding - James Ralston.
08.03.2006 Notification of Director/PDMR Shareholding - Paul Williams.
10.03.2006 Document Available for Viewing at the UKLA - Annual
Report & Accounts and Summary Financial Statement for the Year Ended
31 December 2005 and the Notice of Annual General Meeting.
Copies of the documents published via RNS may be obtained from the Regulatory
News Service provided by the London Stock Exchange at http://
www.londonstockexchange.com/en-gb/pricesnews/marketnews/marketnews.htm and any
related documents are available at the UKLA's Document Viewing Facility,
Financial Services Authority, 25 The North Colonnade, Canary Wharf, London. E14
5HS
2. DOCUMENTS FILED AT COMPANIES HOUSE.
The Company has submitted filings to Companies House in relation to the
Company's annual return and group accounts, the appointment of directors, the
allotment of shares, amendments to the Company's Articles of Association, the
redenomination of the share capital into US Dollars and ordinary and special
resolutions passed at the Company's Annual and Extraordinary General Meetings
held on 5 May 2005 and 12 December 2005 respectively.
Copies of these documents can be found on the Companies House website at http://
www.companieshouse.gov.uk/ or through Companies House Direct at http://
direct.companieshouse.gov.uk/. Alternatively copes can be obtained from
Companies House, Crown Way, Cardiff. CF14 3UZ
3. DOCUMENTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
The Company has submitted filings to the Securities and Exchange Commission by
virtue of having American Depositary Shares listed on the New York Stock
Exchange.
Full details of these filings can be viewed at http://www.sec.gov/edgar/
searchedgar/companysearch.html
4. ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2005.
The Company's Annual Report for the year ended 31 December 2005 can be found on
the Company's website, together with the 2005 Summary Financial Statement.
Copies can be located on the Company's website at http://www.smith-nephew.com/
and http://www.smith-nephew.com/investors/annualreport2005/annualreport2005.pdf
Copies of all the documents referred to above are also available for inspection
at the Company's registered office; 15 Adam Street, London. WC2N 6LA during
normal business hours.
In accordance with Article 27(3) of the Prospectus Directive Regulation, it is
acknowledged that whilst the information referred to above was up to date at the
time of publication, such disclosures may, at any time, become out of date due
to changing circumstances.
Further information regarding the Company and its activities can be located on
the Company's website http://www.smith-nephew.com